How to buy Profound Medical stock (PROF)

Profound Medical is a medical devices business based in the US. Profound Medical shares (PROF) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.15 – a decrease of 1.38% over the previous week. Profound Medical employs 131 staff and has a trailing 12-month revenue of around $9 million.

Our top picks for where to buy Profound Medical stock

Buy Profound Medical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Profound Medical stock price (NASDAQ: PROF)

Use our graph to track the performance of PROF stocks over time.

Profound Medical shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$7.15
52-week range	$6.88 - $11.42
50-day moving average more info button	$7.70
200-day moving average more info button	$8.28
Wall St. target price	$15.30
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.34

Is it a good time to buy Profound Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Profound Medical price performance over time

Historical closes compared with the close of $7.05 from 2024-12-26

1 week (2024-12-20)	-2.76%
1 month (2024-11-27)	-13.50%
3 months (2024-09-27)	-10.98%
6 months (2024-06-28)	-15.97%

1 year (2023-12-28)	-10.19%
2 years (2022-12-28)	-30.40%
3 years (2021-12-28)	11.28
5 years (2019-12-27)	10.67

Profound Medical financials

Revenue TTM	$9 million
Gross profit TTM	$3 million
Return on assets TTM	-44.62%
Return on equity TTM	-90.17%
Profit margin	0%
Book value	$1.26
Market Capitalization more info button	$209.6 million

TTM: trailing 12 months

Profound Medical share dividends

We're not expecting Profound Medical to pay a dividend over the next 12 months.

Have Profound Medical's shares ever split?

Profound Medical's shares were split on a 1:10 basis on 15 October 2019 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Profound Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Profound Medical shares which in turn could have impacted Profound Medical's share price.

Profound Medical share price volatility

Over the last 12 months, Profound Medical's shares have ranged in value from as little as $6.88 up to $11.42. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Profound Medical's is 0.83. This would suggest that Profound Medical's shares are less volatile than average (for this exchange).

Profound Medical overview

Profound Medical Corp. , together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. .

Frequently asked questions

What percentage of Profound Medical is owned by insiders or institutions?
Currently 6.94% of Profound Medical shares are held by insiders and 35.987% by institutions. How many people work for Profound Medical?
Latest data suggests 131 work at Profound Medical. When does the fiscal year end for Profound Medical?
Profound Medical's fiscal year ends in December. Where is Profound Medical based?
Profound Medical's address is: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5 What is Profound Medical's ISIN number?
Profound Medical's international securities identification number is: CA74319B5027 What is Profound Medical's CUSIP number?
Profound Medical's Committee on Uniform Securities Identification Procedures number is: 74319B502